Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2.

Somatostatin receptor scintigraphy (SRS) is positive in approximately 75% of all patients with neuroendocrine gastroenteropancreatic tumours. This study aimed to identify specific somatostatin receptor (sstr) subtypes, which are responsible for the in vivo binding of the widely used somatostatin analogue, octreotide in human neuroendocrine gastroenteropancreatic tumours. Twelve patients underwent SRS with radiolabelled octreotide. After surgical resection, tumour tissues were analysed in vitro for somatostatin and octreotide binding sites by autoradiography. In addition, for the first time, sstr subtype mRNA expression was examined by semiquantitative reverse transcription polymerase chain reaction (RT-PCR). Tumour tissues from all SRS positive patients were positive by autoradiography. Semiquantitative RT-PCR revealed most prominently sstr2 expression in scintigraphically positive tumours. Two SRS negative tumours contained in vitro octreotide binding sites as well as high levels of sstr1 and sstr2 mRNAs. Positive SRS is mainly due to sstr2. sstr1, 3, 4, and probably 5 are less important for in vivo octreotide binding. False negative scintigraphic results seem to be influenced by factors independent of the expression of specific sstr.

[1]  J. Sung,et al.  Common bile duct stones become smaller after endoscopic biliary stenting. , 1998, Endoscopy.

[2]  M. Bourke,et al.  Biliary and pancreatic strictures complicating endoscopic biliary sphincterotomy (EBS); Features and endoscopic management , 1995 .

[3]  S. Sherman,et al.  Benign biliary strictures: Outcome of endoscopic therapy , 1995 .

[4]  P. Jowell,et al.  Biliary stents decrease the size of retained common bile duct (CBD) stones , 1995 .

[5]  B. Wiedenmann,et al.  Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy. , 1994, Seminars in oncology.

[6]  D. Hoyer,et al.  Molecular Pharmacology of Somatostatin‐receptor Subtypes , 1994, Annals of the New York Academy of Sciences.

[7]  J. Laissue,et al.  Expression of Somatostatin Receptors in Normal, Inflamed, and Neoplastic Human Gastrointestinal Tissues , 1994, Annals of the New York Academy of Sciences.

[8]  E. Krenning,et al.  Somatostatin‐receptor Scintigraphy in Gastroenteropancreatic Tumors , 1994, Annals of the New York Academy of Sciences.

[9]  G. Mengod,et al.  Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. , 1994, Cancer research.

[10]  B. Wiedenmann,et al.  Localisation of neuroendocrine tumours of the upper gastrointestinal tract. , 1994, Gut.

[11]  H. Niznik,et al.  Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28. , 1994, Molecular pharmacology.

[12]  S. Seino,et al.  Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. , 1994, The Journal of clinical investigation.

[13]  M. Greenwood,et al.  All five cloned human somatostatin receptors (hSSTR1-5) are functionally coupled to adenylyl cyclase. , 1994, Biochemical and biophysical research communications.

[14]  B. Wiedenmann,et al.  Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. , 1993, Gastroenterology.

[15]  W. Meyerhof,et al.  Expression Patterns of Rat Somatostatin Receptor Genes in Pre‐ and Postnatal Brain and Pituitary , 1993, Journal of neurochemistry.

[16]  H. Imura,et al.  Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. , 1993, Biochemical and biophysical research communications.

[17]  M. Berelowitz,et al.  Molecular cloning and sequencing of a human somatostatin receptor, hSSTR4. , 1993, Biochemical and biophysical research communications.

[18]  R. Sunahara,et al.  Cloning and expression of a human somatostatin-14-selective receptor variant (somatostatin receptor 4) located on chromosome 20. , 1993, Molecular pharmacology.

[19]  L. Rohrer,et al.  Cloning and characterization of a fourth human somatostatin receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[20]  M. Greenwood,et al.  Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation. , 1993, Biochemical and biophysical research communications.

[21]  L. Kvols,et al.  Evaluation of a radiolabeled somatostatin analog (I-123 octreotide) in the detection and localization of carcinoid and islet cell tumors. , 1993, Radiology.

[22]  G. Bell,et al.  Molecular biology of somatostatin receptors , 1993, Trends in Neurosciences.

[23]  S. Seino,et al.  Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. , 1992, Molecular endocrinology.

[24]  T. Reisine,et al.  Biochemical and Functional Properties of Somatostatin Receptors , 1992, Journal of neurochemistry.

[25]  E. Krenning,et al.  Somatostatin-receptor imaging in the localization of endocrine tumors. , 1990, The New England journal of medicine.

[26]  J. Charboneau,et al.  Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. , 1990, Cancer research.

[27]  H. Bruining,et al.  Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy. , 1990, The Journal of clinical endocrinology and metabolism.

[28]  E. P. Krenning,et al.  LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN , 1989, The Lancet.

[29]  Jamel Chelly,et al.  Transcription of the dystrophin gene in human muscle and non-muscle tissues , 1988, Nature.

[30]  J. Reubi,et al.  Hormone-producing gastrointestinal tumors contain a high density of somatostatin receptors. , 1987, The Journal of clinical endocrinology and metabolism.

[31]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[32]  J. Klijn,et al.  Somatostatin receptors in human endocrine tumors. , 1987, Cancer research.

[33]  L. Kedes,et al.  Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. , 1984, Nucleic acids research.

[34]  D. Huglo,et al.  Iodine-123-Tyr-3-octreotide uptake in pancreatic endocrine tumors and in carcinoids in relation to hormonal inhibition by octreotide. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  H. Bihl,et al.  Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogs. , 1993, Hormone and metabolic research. Supplement series.

[36]  S. Seino,et al.  Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. , 1992, Proceedings of the National Academy of Sciences of the United States of America.